Abstract:The recent technical and computational advances in single-cell sequencing technologies have significantly broaden our toolkit to study tumor microenvironment (TME) directly from human specimens. The TME is the complex and dynamic ecosystem composed of multiple cell types, including tumor cells, immune cells, stromal cells, endothelial cells, and other non-cellular components such as the extracellular matrix and secreted signaling molecules. The great success on immune checkpoint blockade therapy has highlighted the importance of TME on anti-tumor immunity and has made it a prime target for further immunotherapy strategies. Applications of single-cell transcriptomics on studying TME has yielded unprecedented resolution of the cellular and molecular complexity of the TME, accelerating our understanding of the heterogeneity, plasticity, and complex cross-interaction between different cell types within the TME. In this review, we discuss the recent advances by single-cell sequencing on understanding the diversity of TME and its functional impact on tumor progression and immunotherapy response driven by single-cell sequencing. We primarily focus on the major immune cell types infiltrated in the human TME, including T cells, dendritic cells, and macrophages. We further discuss the limitations of the existing methodologies and the prospects on future studies utilizing single-cell multi-omics technologies. Since immune cells undergo continuous activation and differentiation within the TME in response to various environmental cues, we highlight the importance of integrating multimodal datasets to enable retrospective lineage tracing and epigenetic profiling of the tumor infiltrating immune cells. These novel technologies enable better characterization of the developmental lineages and differentiation states that are critical for the understanding of the underlying mechanisms driving the functional diversity of immune cells within the TME. We envision that with the continued accumulation of single-cell omics datasets, single-cell sequencing will become an indispensable aspect of the immune-oncology experimental toolkit. It will continue to drive the scientific innovations in precision immunotherapy and will be ultimately adopted by routine clinical practice in the foreseeable future.

Comprehensive description of the current breast cancer microenvironment advancements via single-cell analysis

Single-Cell Profiling to Explore Immunological Heterogeneity of Tumor Microenvironment in Breast Cancer

Application of single-cell sequencing to the research of tumor microenvironment

Research progress and the prospect of using single-cell sequencing technology to explore the characteristics of the tumor microenvironment

Single-Cell Informatics for Tumor Microenvironment and Immunotherapy

Cancer Biology Deciphered by Single-Cell Transcriptomic Sequencing

Applications of Single-Cell Omics to Dissect Tumor Microenvironment

[Advancements in Single-cell RNA Sequencing Technology in the Study of the Tumor Microenvironment in Lung Cancer]

Tumor microenvironment as a complex milieu driving cancer progression: a mini review

Insights Gained from Single-Cell Analysis of Immune Cells in the Tumor Microenvironment

Understanding Tumor Ecosystems by Single-Cell Sequencing: Promises and Limitations

Applications of Single-Cell Omics in Tumor Immunology

Tumor-related Microbiome in the Breast Microenvironment and Breast Cancer

Single cell RNA sequencing for breast cancer: present and future

The Cellular Composition of the Tumor Microenvironment is an Important Marker for Predicting Therapeutic Efficacy in Breast Cancer

Single-cell landscape of intratumoral heterogeneity and tumor microenvironment remolding in pre-nodal metastases of breast cancer

Single-Cell RNA-Sequencing: Opening New Horizons for Breast Cancer Research

Tumor Microenvironment Heterogeneity, Potential Therapeutic Avenues, and Emerging Therapies

New horizons in tumor microenvironment biology: challenges and opportunities

Advancing Breast Cancer Heterogeneity Analysis: Insights from Genomics, Transcriptomics and Proteomics at Bulk and Single-Cell Levels

Recent progress and applications of single-cell sequencing technology in breast cancer